SRPT — Sarepta Therapeutics Inc. Common Stock (DE) price, chart and key statistics

Price data

Price

$17.10

YTD price return

-20.54%

YTD total return

-20.54%

Next earnings

Nov 2, 2026

Market cap

1.8B2016-12 1.5B2026-10 1.8B+20.7% over the window

Enterprise value

2.1B

Shares outstanding

105.6M2016-06 47.9M2026-06 105.6M+120.5% over the window

52W low

$14.68

52W high

$24.68

From 52W high

-30.71%

From 52W low

+16.49%

52W range

24%

Volume

Rel volume

3.11×

30D volume

3.2M

30D $ vol

59.9M

Fundamentals

Sales (ttm)

2B2016-12 5.4M2026-06 2B+36320.3% over the window

Sales/share

$18.692016-12 $0.102026-06 $18.69+18799.7% over the window

EPS (ttm)

-$1.602016-06 -$5.172026-06 -$1.60-69.1% over the window

FCF (ttm)

81.8M2016-06 -185.4M2026-06 81.8M-144.2% over the window

FCF/share

$0.772016-06 -$3.872026-06 $0.77-120.0% over the window

Book value/share

$14.462016-06 $2.542026-06 $14.46+470.4% over the window

Net margin

-6.93%2016-12 -4930.2%2026-06 -6.9%-99.9% over the window

ROE

-8.95%2016-06 -196.5%2026-06 -8.9%-95.4% over the window

ROA

-4.29%2016-06 -117.0%2026-06 -4.3%-96.3% over the window

Debt / equity

0.55×2016-12 0.052026-06 0.55+957.3% over the window

Current ratio

4.422016-06 2.292026-06 4.42+93.2% over the window

Growth (CAGR, ttm) · 10Y

Sales

+6.86%2024-12-31 → 2026-06-301.8B → 2B (+10.4% total)+25.30%2023-06-30 → 2026-06-301B → 2B (+96.8% total)+26.90%2021-06-30 → 2026-06-30600.1M → 2B (+229.0% total)+101.66%2015-12-31 → 2026-06-301.3M → 2B (+157469.4% total)

Shares

+8.10%2025-06-30 → 2026-06-3097.7M → 105.6M (+8.1% total)+4.23%2023-06-30 → 2026-06-3093.3M → 105.6M (+13.2% total)+5.76%2021-06-30 → 2026-06-3079.8M → 105.6M (+32.3% total)+8.23%2016-06-30 → 2026-06-3047.9M → 105.6M (+120.5% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+0.96%2024-12-31 → 2026-06-30$18.43 → $18.69 (+1.4% total)+20.22%2023-06-30 → 2026-06-30$10.76 → $18.69 (+73.8% total)+19.99%2021-06-30 → 2026-06-30$7.52 → $18.69 (+148.7% total)+86.17%2015-12-31 → 2026-06-30$0.03 → $18.69 (+68022.9% total)

Book value/share

+0.61%2025-06-30 → 2026-06-30$14.38 → $14.46 (+0.6% total)+22.08%2023-06-30 → 2026-06-30$7.95 → $14.46 (+82.0% total)+18.95%2021-06-30 → 2026-06-30$6.08 → $14.46 (+138.1% total)+19.02%2016-06-30 → 2026-06-30$2.54 → $14.46 (+470.4% total)

Price

-26.75%2025-10-16 → 2026-10-16$23.34 → $17.10 (-26.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-47.40%2023-10-16 → 2026-10-16$117.55 → $17.10 (-85.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-27.29%2021-10-15 → 2026-10-16$84.19 → $17.10 (-79.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-10.57%2016-10-14 → 2026-10-16$52.28 → $17.10 (-67.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-26.75%2025-10-16 → 2026-10-16$23.34 → $17.10 (-26.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-47.40%2023-10-16 → 2026-10-16$117.55 → $17.10 (-85.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-27.29%2021-10-15 → 2026-10-16$84.19 → $17.10 (-79.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-10.57%2016-10-14 → 2026-10-16$52.28 → $17.10 (-67.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-10.7×2016-12 -6.152026-10 -13.22+114.9% over the window

Fwd P/E

7.4×

P/S (ttm)Market cap ÷ TTM revenue.

0.9×2016-12 1195.062026-10 0.92-99.9% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

1.2×2016-12 3.662026-10 1.18-67.7% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

22.1×2016-12 -7.512026-10 22.08-394.0% over the window

EV/Sales (ttm)

1.1×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

4.53%2016-09 -13.3%2026-06 4.3%-132.4% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 105.6M ÷ 97.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-8.10%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-8.10%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-8.10%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-20M) ÷ today's market cap ($1.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-1.11%2016-09 -32.4%2026-06 -1.1%-96.7% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-20M + TTM dividends $0) ÷ today's market cap ($1.8B). Same caveat as the cash buyback yield.

-1.11%2016-09 -32.4%2026-06 -1.1%-96.7% over the window

Vs own 10Y history

P/S

4th

P/B

2nd